���˿���

The additional drug treatmentand rehabilitation money was allocated to drug action teams (DAT) on the basis of the quantified impact of DAT proposals on the three identified national prioritiesnamely: increasing the number of clients entering treatment; reducing waiting timesand increasing the range of interventions, and on evidence of deliverability withinagreed timescales.

In terms of “evidence of deliverabilitywithin agreed timescales” we considered DAT performance to date and looked for clearlyplanned, well thought out proposals which included some indication of how the aimof the proposal would be achieved with timescales and a brief breakdown of cost.In particular we looked for proposals which complemented existing provision (i.e.filled a clearly identified and evidenced gap in existing services or provided additionalityto existing provision), proposals which demonstrated a strategic approach to developmentand proposals which had secured part-funding from elsewhere. The underlying principlesof Best Value and Integrated Care were also considered.

On 1 July 2005, the ScottishExecutive announced the following allocation by drug action team (DAT) area. Thesum of proposals received from each DAT is also detailed.

Drug Action Team	Sum of Proposals	Allocation
Aberdeen City	£844,532	£102,000
Aberdeenshire	£816,000	£68,000
Angus	£601,773	£77,584
Argyll and Clyde	£1,542,759	£238,000
Ayrshire and Arran	£966,123	£117,781
Borders	£315,702	£18,877
Dumfries and Galloway	£574,000	£210,800
Dundee City	£530,458	£251,038
East Lothian	£450,322	£105,654
Edinburgh City	£1,062,435	£470,564
Fife	£1,264,682	£549,212
Forth Valley	£1,616,160	£242,680
Greater Glasgow	£1,840,350	£904,200
Highland	£1,603,000	£54,400
Lanarkshire	£682,878	£68,000
Midlothian	£354,029	£20,225
Moray	£256,634	£68,000
Orkney	£124,754	£19,720
Perth and Kinross	£547,000	£77,584
Shetland	£60,000	£13,600
Western Isles	£71,600	£9,560
West Lothian	£596,740	£329,058

 

Following reassurances fromdrug action teams of expected impact, it is anticipated that the funding will beallocated to the relevant NHS board in August.

The information requested isnot collected centrally by the Scottish Renal Registry (SRR), which is thesource for national data on renal dialysis. The figures provided in the answerto S2W-9961 were collected specifically for that question. Iunderstand that the SRR Steering Group is now considering whether these datashould be collected routinely on a routine basis in future.

The SRR data suggest thatthe majority of patients who dialyse outwith their own NHS board area do sofrom choice.

All NHS boards havediscretion to reimburse patient travelling expenses where it is viewed to be anextension of treatment costs and is deemed to be clinically necessary.

The number of patients in Scotland usinghome dialysis as treatment for established renal failure on 31 December foreach year since 1999 is set out in the table. Due to the small numbersinvolved, the figures have not been presented by age or NHS board area.

Year	No. of Patients
1999	54
2000	51
2001	46
2002	41
2003	43
2004	43*

Source:Scottish Renal Registry.

Note: * the Scottish Renal Registry continually refines the data it holds, and the figureof 44 given in the Answer to the previous Question reflected the data as theystood at the time it was answered.

The criteria for eligibilityfor travelling expenses are contained within The National Health Service (TravellingExpenses and Remission of Charges) (Scotland) (No. 2) Regulations 2003 asamended by The National Health Service (Travelling Expenses and Remission ofCharges) (Scotland) Amendment Regulations 2004, The National Health Service(Travelling Expenses and Remission of Charges) (Scotland) Amendment (No. 2)Regulations 2004, The National Health Service (Travelling Expenses and Remissionof Charges) (Scotland) Amendment Regulations 2005 and The National HealthService (Travelling Expenses and Remission of Charges) (Scotland) Amendment(No. 2) Regulations 2005. In addition NHS Boards have discretion to reimbursetravelling expenses for patients who are not eligible under the statutoryschemes where it is deemed to be an extension of treatment costs. There are currentlyno plans to review the criteria.

The information is set outin the table. Due to the small number of children involved, the data have notbeen split by age.

NHS Board Area	1999	2000	2001	2002	2003	2004
Argyll and Clyde	81	79	96	106	112	124
Ayrshire and Arran	61	63	77	87	95	97
Borders	14	15	16	21	19	22
Dumfries and Galloway	40	38	44	44	48	43
Fife	68	75	78	78	86	94
Forth Valley	46	59	63	70	77	78
Greater Glasgow	268	276	273	286	293	288
Grampian	96	106	128	150	135	150
Highland	28	32	46	53	69	72
Lanarkshire	115	128	142	161	168	162
Lothian	168	159	156	168	182	206
Tayside	105	99	94	107	116	121
No NHS Board reported *	7	9	11	11	14	48

Source:Scottish Renal Registry.

Notes:

On groundsof patient confidentiality, the Island NHS Boards have not been includedbecause of the very small patient numbers.

* NHS boardof residence is derived from the patient’s postcode. Some postcodes weremissing. It is not possible to determine if these patients are receivingdialysis in their own NHS Board area.

The number of renaltransplants carried out in Scotland in each year since 1999 is set out in the table. Thefigures include patients who received a kidney only transplant, as well askidney/liver, kidney/pancreas and kidney/heart transplants.

Year	Cadaveric Donor	Living Donor	Total
1999	138	27	165
2000	138	41	179
2001	121	35	156
2002	114	31	145
2003	105	40	145
2004	94	30	124

Source; UKTransplant.

The number of patients in Scotland onthe active waiting list for a kidney transplant in each year since 1999 is setout in the table.

Year	No. of Patients
1999	491
2000	466
2001	455
2002	481
2003	433
2004	471

Source: UKTransplant.

Information on all acuteintoxication discharges from general acute hospitals for people aged under 24during 1999-2000 to 2004-05 is shown in the following table.

ScottishGeneral Acute Hospital ^1,2 Discharge Records for Patients forPatients aged under 24 with an Explicit Diagnosis of Acute Intoxication ³; 1999-2000 to 2004-05

Area of Residence	Discharge Period
	1999-2000	2000-01	2001-02	2002-03	2003-04	2004-05 p
Total	2,314	2,023	2,182	2,047	1,757	1,553
Scotland Residents	2,259	1,988	2,127	2,003	1,716	1,531
Argyll and Clyde	213	192	171	173	190	173
Ayrshire and Arran	309	256	322	395	344	301
Borders	55	53	60	83	66	53
Dumfries and Galloway	50	36	26	29	23	21
Fife	122	106	94	106	69	63
Forth Valley	53	69	97	61	74	45
Grampian	355	237	283	240	183	146
Greater Glasgow	332	282	277	212	143	182
Highland	149	162	194	185	158	113
Lanarkshire	157	150	201	164	102	138
Lothian	208	193	163	121	135	133
Tayside	203	201	180	162	142	101
Islands 4	53	51	59	72	87	62
Other 5	55	35	55	44	41	22

Source:SMR01 (valid records only).

Date: 25 July 2005.

Ref:20052232.

Notes:

^pprovisional.

1. Includesacute hospitals (excludes maternity hospitals, mental illness hospitals andpsychiatric units).

2.Information on hospital discharges relates to episodes of inpatient or day casecare rather than individual patients. The same patient may account for severalhospital admissions during the course of a year (or across years) and will becounted each time in the attached table. Transfer cases have been included.

3.Diagnostic information is defined by using the World Health Organisation’sInternational Classification of Diseases 10th Revision (ICD10). AcuteIntoxication: F100

4. Orkney,Shetland and Western Isles

5. Patientsresident outwith Scotland and patients where the area ofresidence is not known.